Chronic Diseases Prevention Review (Online ISSN: 2158-0820)

by  Nianli Xing, XiaoYing Jiang

Chronic Diseases Prevention Review 2020 4(13) 1-8; published online  30 January 2020

Abstract: To summarize and comparatively analyze the implementation effect of capitation in different countries or regions．Using "capitation" as keywords, the literature was searched in PubMed, CNKI, and Wanfang, and the effects of the capitation were summarized. The evaluation of the effect of the current research on capitation mainly includes four aspects: medical expenses, utilization of health services, quality of health services, and satisfaction. Due to the different characteristics of different capitation projects, the evaluation of the effect of capitation is also different. More research is still needed to assess the effectiveness of capitation projects.

by  Han Zhou, Rui Xu, Kunxing Ding, Cuiping Liu, Feng Zhong

Chronic Diseases Prevention Review 2020 4(13) 9-21; published online  30 January 2020

Abstract: Sleep disorders have become an important public health issue affecting people's physical health. In recent years, the impact of mobile phone radio-frequency (RF) radiation on the outcome of sleep caused the attention of scholars. We systematically searched EMBASE, Web of Science, Cochrane Library and PubMed until November 2018. All articles on the relationship between radiofrequency radiation and sleep results from polysomnography were included. These articles were randomized controlled trials (RCT) in English only. The aim was to investigate the effects of radio frequency (RF) radiation from mobile phones on sleep outcomes. 17 RCTs, including 398 participants, met the criteria for a meta-analysis. The results showed that exposure to mobile phone radio frequency radiation had no effect on sleep staging indicators and sleep quality indicators. However, results of subgroup analysis according to the exposure frequency, publication years, and exposure time demonstrated that exposure to non-217Hz RF radiation could increase arousal-index per hour (standardized mean difference = 1.22, 95% confidence interval [0.68, 1.76]; p < 0.001). The articles published before 2000 showed that total sleep time (mean difference = 4.80, 95% confidence interval=[3.70, 5.90]; p < 0.001) had increased, while articles published after 2001 showed that total sleep time (mean difference = -2.56, 95% confidence interval= [-4.25, -0.87]; p = 0.003) had decreased. RF exposure before sleep could increase the time of stage 1 (mean difference = 0.91, 95% confidence interval= [0.32, 1.50]; p = 0.003). Therefore, short-term exposure to cell phone RF radiation had no impacts on people's overall sleep outcomes.

by  Sifei Wu

Chronic Diseases Prevention Review 2020 4(13) 22-25; published online  25 February 2020

Abstract: To explore the clinical effect of oseltamivir phosphate in the treatment of influenza in children. 84 children with influenza treated in our hospital from February 2019 to February 2020 were selected. The patients were divided into control group and the observation group by random number table method, with 42 cases in each group. The control group using conventional antiviral treatment, and the observation group was treated with oseltamivir phosphate and conventional antiviral treatment, to compare the therapeutic effect of two groups of children. The total effective rates of treatment in the control group and the observation group were 85.71% and 97.62%, respectively(P＜0.05). Compared with the control group, the symptom relief time in the observation group was significantly faster(P＜0.05). The clinical efficacy of oseltamivir phosphate in treating children's influenza is significant, and it can help patients to quickly reduce clinical symptoms, shorten the treatment time, and improve the prognosis of children. It has high clinical value in the treatment of childhood influenza.

by  Guicang Zhou, Tang Li, Lingyan Qiao, Jie Wang, Juan Ge, Cheng Li

Chronic Diseases Prevention Review 2020 4(13) 26-30; published online  25 February 2020

Abstract: To analysis of the efficacy of aromatase inhibitor combined with recombinant human growth hormone and provide a clinical basis for the treatment of boys with larger bone age. All the boys were diagnosed as short stature and bone age≥13 years in the Department of Endocrinology and Metabolism, Qingdao Women and Children Hospital from October 2017 to October 2019. Both were treated with aromatase inhibitor and recombinant human growth hormone. Observed the changes in height, weight, growth velocity, bone age, predicted adult height, testosterone, insulin-like growth factor-1 and side effects after baseline, 6 months and 12 months of treatment. After treatment with aromatase inhibitor and recombinant human growth hormone, the testosterone and insulin-like growth factor-1 levels in the children increased significantly, the bone age progressed slowly, and growth velocity and predicted adult height are improved, which was statistically significant (P < 0.01). During the treatment, the children were monitored for normal masculinization, and had no significant effect on BMI (P > 0.05), and the safety and tolerability were good. Aromatase inhibitor combined with recombinant human growth hormone to treat short stature boys with larger bone age can delay bone age progression, improve predicted adult height, and have good safety and tolerability in the short term.